Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00266552
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2005-12-16
Brief Title:
A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild Moderate or Borderline Mental Retardation
Sponsor:
Janssen Pharmaceutica NV Belgium
Organization:
Janssen Pharmaceutica NV Belgium
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Oppositional Defiant Disorder |
| Conduct Disorder |
| Disruptive Behavior Disorder |